Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir (EraMune02)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Objectif Recherche Vaccins SIDA

Pfizer

Merck

Information provided by (Responsible Party):

Robert L. Murphy, Northwestern University

ClinicalTrials.gov Identifier:

NCT00976404

First received: September 9, 2009

Last updated: June 29, 2012

Last verified: June 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)